Hikma Pharmaceuticals PLC (HIK) — Financial Flexibility Index
Hikma Pharmaceuticals PLC (HIK) has a Financial Flexibility Index of 0.08x as of June 2025. Free cash flow of GBX229.00 Million (operating CF GBX161.00 Million minus capex GBX68.00 Million) represents 0% of total liabilities (GBX3.00 Billion). Check Hikma Pharmaceuticals PLC (HIK) strategic asset index to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Hikma Pharmaceuticals PLC Financial Flexibility Index (2002–2024)
Historical Financial Flexibility Index trend for Hikma Pharmaceuticals PLC across 23 annual periods. See Hikma Pharmaceuticals PLC (HIK) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Hikma Pharmaceuticals PLC (2002–2024)
Year-by-year free cash flow to debt coverage for Hikma Pharmaceuticals PLC. For the full company profile including market capitalisation, see market cap of Hikma Pharmaceuticals PLC.
| Year | Flexibility Index | Free Cash Flow (GBX) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.26x | GBX729.00 Million | GBX564.00 Million | GBX2.81 Billion | ▼ -17.6% |
| 2023 | 0.31x | GBX777.00 Million | GBX608.00 Million | GBX2.47 Billion | ▼ -3.3% |
| 2022 | 0.33x | GBX755.00 Million | GBX530.00 Million | GBX2.32 Billion | ▼ -28.6% |
| 2021 | 0.46x | GBX867.00 Million | GBX638.00 Million | GBX1.91 Billion | ▲ +31.4% |
| 2020 | 0.35x | GBX688.00 Million | GBX464.00 Million | GBX1.99 Billion | ▼ -5.2% |
| 2019 | 0.37x | GBX658.00 Million | GBX472.00 Million | GBX1.80 Billion | ▲ +22.5% |
| 2018 | 0.30x | GBX537.00 Million | GBX430.00 Million | GBX1.80 Billion | ▲ +0.9% |
| 2017 | 0.30x | GBX550.00 Million | GBX443.00 Million | GBX1.86 Billion | ▲ +39.1% |
| 2016 | 0.21x | GBX415.00 Million | GBX293.00 Million | GBX1.95 Billion | ▼ -40.9% |
| 2015 | 0.36x | GBX448.00 Million | GBX366.00 Million | GBX1.25 Billion | ▼ -27.8% |
| 2014 | 0.50x | GBX516.00 Million | GBX425.00 Million | GBX1.03 Billion | ▲ +12.7% |
| 2013 | 0.44x | GBX396.00 Million | GBX337.00 Million | GBX895.00 Million | ▲ +43.3% |
| 2012 | 0.31x | GBX272.35 Million | GBX182.16 Million | GBX882.26 Million | ▲ +32.8% |
| 2011 | 0.23x | GBX180.64 Million | GBX102.64 Million | GBX777.01 Million | ▼ -55.7% |
| 2010 | 0.53x | GBX191.98 Million | GBX138.79 Million | GBX365.52 Million | ▲ +22.2% |
| 2009 | 0.43x | GBX145.90 Million | GBX105.52 Million | GBX339.46 Million | ▲ +24.5% |
| 2008 | 0.35x | GBX123.39 Million | GBX57.87 Million | GBX357.46 Million | ▲ +65.2% |
| 2007 | 0.21x | GBX98.11 Million | GBX43.12 Million | GBX469.38 Million | ▼ -64.9% |
| 2006 | 0.59x | GBX82.43 Million | GBX29.99 Million | GBX138.56 Million | ▲ +15.9% |
| 2005 | 0.51x | GBX56.70 Million | GBX32.71 Million | GBX110.48 Million | ▼ -4.0% |
| 2004 | 0.53x | GBX54.17 Million | GBX32.84 Million | GBX101.31 Million | ▲ +67.3% |
| 2003 | 0.32x | GBX18.35 Million | GBX18.35 Million | GBX57.39 Million | ▲ +4.3% |
| 2002 | 0.31x | GBX14.35 Million | GBX14.35 Million | GBX46.84 Million | — |